European researchers are heading to some of the deepest and coldest places on the planet as part of a race against time to find new medicines that can protect society from increasingly drug-resistant bacteria.
Supplies of new antibiotics are running dry, and if nothing is done to fight the problem, then scientists believe that within 10 to 20 years, bacteria will have become resistant to all major antibiotics, meaning simple infections could be fatal.
More than a third of EU countries have experienced a significant increase in drug-resistant E. coli and klebsiella, a bacteria which can cause pneumonia, over the past four years.
On top of that, there has not been a new antibiotic registered since 2003, and the marine environment represents an untapped source for new biologically active molecules, in particular antibiotics.
As part of the EU-funded PharmaSea project, scientists are looking for new drugs in some of the deepest trenches in the oceans, in the belief that evolution may have progressed differently there.
PharmaSea, backed by more than EUR 9.5 million from the EU, will collect and screen samples of mud and sediment from the huge, previously untapped oceanic trenches. The team comprises experts from Belgium, Denmark, Germany, Ireland, Italy, Norway, Spain, Switzerland and the UK.
They have a specific goal in mind - to discover five new antibiotics ready for patient use by the end of the current decade, sourced from the diversity of marine life in our oceans.
Access to really deep water is restricted to oceanography ships and deep sea sampling equipment, so the team will use ‘inexpensive and robust’ equipment based on that used in the salvage sector.
For sampling sediments from the deep seas, the team of Prof. Marcel Jaspars (University of Aberdeen) will employ strategies used by the salvage industry. © Marcel Jaspars
The team, led by Professor Marcel Jaspars of the University of Aberdeen in Scotland, will search for organisms by lowering sediment collecting equipment into the trench bed from fishing vessels.
Having scoured for marine organisms more than 2 000 metres below sea level, scientists will then attempt to grow unique bacteria and fungi from the sediment that can be extracted to isolate novel drug-like molecules for testing.
The first tests will be carried out in the autumn in the Eastern Pacific Ocean, off Chile and Peru, followed by tests in the Arctic and Antarctic.
‘Our guiding philosophy is simple,’ said Prof. Jaspars. ‘Unique and extreme environments can yield new species of marine micro-organisms. By choosing deep and cold marine environments we hope to tap novel diversity not seen before. Deep ocean trenches are islands of diversity in which evolution may have progressed differently.’
One of the main aims is to look for new antibiotics in newly discovered marine bacteria and the team will focus on drug discovery for neurological, inflammatory and other infectious diseases as well as in the area of cancer treatment.
‘By choosing deep and cold marine environments we hope to tap novel diversity not seen before.’
Professor Marcel Jaspars, University of Aberdeen, Scotland
By the end of the project, in September 2016, it is hoped this innovative form of bio-prospecting will have significantly advanced the fight against antibiotic resistant bacteria.
Marine and coastal environments contain about 90 % of all organisms on Earth, and European seas are home to over 36 000 known species - with thousands as yet unclassified.
‘Many of these organisms produce a wealth of chemical compounds,’ said Professor Heikki Vuorela, of the University of Helsinki. ‘Our hope is that any discoveries may pave the way to a healthier future, both for people and the marine environment.’
When an outbreak strikes, speed is critical. Health workers must act quickly not only to contain and treat an emerging or re-emerging disease, but also to use this window to evaluate potential treatments and vaccines. And the challenge becomes even greater in sub-Saharan Africa when you’re trying to develop new approaches in the face of multiple emerging diseases.
Understanding the progression from the stepping reflex to independent walking could help find new therapies for children with cerebral palsy (CP) – a movement disability caused by brain damage before, during or shortly after birth.
Nature provides people with everything from food and water to timber, textiles, medicinal resources and pollination of crops. Now, a new approach aims to measure exactly what a specific ecosystem supplies in order to incentivise decision-makers and businesses to help combat biodiversity loss.
Europe’s position on privacy, regulation and competition could be a key way to attract entrepreneurs who share those values but there is still some work to do in encouraging ambition, according to Nicklas Bergman, a Swedish entrepreneur and technology investor. Over the past two years, he and other entrepreneurs have advised the European Commission on the design of the European Innovation Council (EIC), an initiative to support companies, researchers and entrepreneurs hoping to start their own business or scale up their projects internationally. The second phase of the pilot was launched on 18 March 2019.
To protect species, we need to speak the language of business, say experts.
He has advised the EU on its new European Innovation Council.
Species loss needs urgent international action, says Prof. Georgina Mace.